SPOTLIGHT -
ASCRS 2024: At Eyecelerator, a New Zealand-based startup pitches eye drops for keratoconus
Before the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment.
Vision Expo East 2024: Continuing education in your practice with Leonardo
Nicholas Gilberg, OD, with EssilorLuxxotica's Leonardo team walks through the basics of the education software that can be implemented in any practice.
Vision Expo East 2024: Zyloware Eyewear Co-CEOs win Optical Lifetime Achievement Award
Vision Expo East 2024: Technological advancements and excellence in treatment collide
Laura Periman, MD, talks through what was gained from the conference, from becoming acquainted with new technological advancements to renewing passion for dry eye care.
Vision Expo East 2024: Getting your patients excited about contact lenses
Scott Moscow, OD, talks his practice's contact lens "test-driving" option and how to get patients on board with trying out new corrective eyewear.
Vision Expo East 2024: The latest in frames purchasing trends with Alysse Henkel
Alysse Henkel, vice president of research and inSights at The Vision Council, details recent research conducted by the company regarding consumer purchasing habits and trends.
Women in ophthalmology series: Dr Filomena Ribeiro on the importance of equity in education
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them.
FDA approves clobetasol propionate 0.05% for ocular pain, inflammation following surgery
The approval marks the first new steroid on the ophthalmic market in more than 15 years.
Looking back: The top stories in European eye care from 2023
A review of the most important content from Europe throughout 2023.
Heidelberg Engineering announces FDA clearance for ANTERION diagnostic platform
The ‘all-in-one’ platform combines specialized imaging and three new FDA-approved apps with a focus on metrics, corneal imaging, and cataract care.
Orbis and Heidelberg Engineering announce new partnership at ESCRS congress
The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.